DOC Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Based on the data provided, Healthpeak Properties Inc (DOC) is not a strong buy for a beginner investor with a long-term strategy at this time. The stock lacks clear positive momentum, has weak financial performance, and no strong trading signals or catalysts to justify immediate investment. Holding off for now is recommended.
The MACD histogram is positive but contracting, indicating weakening bullish momentum. RSI is neutral at 50.037, and moving averages are converging, showing no clear trend. The stock is trading near its pivot point of 17.382, with support at 16.926 and resistance at 17.839.
The company is spinning off its senior housing portfolio into a new REIT, Janus Living, which could allow Healthpeak to focus on outpatient medical and life science assets. This strategic move may improve operational focus in the long term.
Recent financial performance is weak, with a significant drop in net income (-236.86% YoY) and EPS (-241.67% YoY). Analyst sentiment is neutral to negative, with a downgrade from Argus and a reduced price target from Wells Fargo. Additionally, the stock has shown no significant insider or hedge fund activity, and there are no strong trading signals.
In Q3 2025, revenue increased marginally by 0.78% YoY to $705.87M. However, net income dropped significantly to -$117.26M (-236.86% YoY), and EPS fell to -$0.17 (-241.67% YoY). Gross margin also declined slightly by 2.12% YoY to 58.65%. Overall, the financial performance is weak.
Analyst sentiment is neutral to negative. Argus downgraded the stock to Hold from Buy, and Wells Fargo lowered its price target to $18 from $19, citing potential occupancy loss in the near term before a recovery in the second half of 2026.
